Sanara MedTech
SMTI
75 hedge funds and large institutions have $42.1M invested in Sanara MedTech in 2026 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 4 closing their positions.
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
113% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 15
64% more capital invested
Capital invested by funds: $25.6M → $42.1M (+$16.5M)
15% more funds holding
Funds holding: 65 → 75 (+10)
3.2% more ownership
Funds ownership: 16.28% → 19.48% (+3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.49M |
| 2 |
Goldman Sachs
New York
|
+$1.09M |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$900K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$654K |
| 5 |
Walleye Capital
New York
|
+$630K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$555K |
| 2 |
Squarepoint
New York
|
-$409K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$278K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$217K |
| 5 |
SIC
Salem Investment Counselors
Winston Salem,
North Carolina
|
-$187K |
SMTI Hedge Fund Activity: Q2 2026 in Review
75 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2026, worth a combined $42.1M — up 64% from $25.6M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new SMTI positions and 4 closed out — a net gain of 12 holders — while 32 added to existing stakes and 15 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $1.49M. The largest seller was Marshall Wace, cutting an estimated $555K.
- 75 institutional investors held Sanara MedTech (SMTI) as of Q2 2026, up from 65 in Q1 2026.
- Funds reported $42.1M of Sanara MedTech stock for Q2 2026, up 64% quarter-over-quarter.
- 16 funds opened new Sanara MedTech positions in Q2 2026 and 4 closed out, a net change of +12 holders.
- The largest Sanara MedTech buyer in Q2 2026 was AQR Capital Management, an estimated $1.49M added.
- The largest Sanara MedTech seller in Q2 2026 was Marshall Wace, an estimated $555K sold.
Based on aggregated 13F filings for Q2 2026.